Related Experiment Video
Updated: May 13, 2026

09:06
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
Published on: November 11, 2021
Mdm2 increases cellular invasiveness by binding to and stabilizing the Slug mRNA
Chan-Hun Jung1, Jongdoo Kim, Jong Kuk Park
1Division of Radiation Cancer Biology, Korea Institute of Radiological & Medical Sciences, Seoul 139-706, Republic of Korea.
Cancer Letters
|February 27, 2013
Summary
The Mdm2 oncoprotein stabilizes Slug mRNA, promoting cancer progression. This Mdm2-Slug interaction enhances tumor invasiveness, particularly in p53-null cancer cells, revealing a p53-independent mechanism.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Mdm2 is an oncoprotein that targets the tumor suppressor p53 for degradation.
- The regulation of tumor suppressor proteins and oncogenic pathways is crucial in cancer progression.
Purpose of the Study:
- To investigate the role of Mdm2 in regulating Slug mRNA and protein levels.
- To determine if Mdm2-mediated Slug regulation impacts cancer cell behavior independently of p53.
Main Methods:
- Analysis of mRNA and protein levels of Slug in cancer cells with and without p53.
- Assessment of Mdm2's binding to Slug mRNA.
- Evaluation of Slug-dependent cellular events like E-cadherin levels and invasiveness.
Main Results:
- Mdm2 binding to Slug mRNA increases its stability and mRNA levels in both p53-null and p53-expressing cells.
- Mdm2 elevates Slug protein levels exclusively in p53-null cancer cells.
- Mdm2 induces Slug-dependent decreases in E-cadherin and increases in cellular invasiveness, but only in p53-null cells.
Conclusions:
- Mdm2 stabilizes Slug mRNA, representing a novel mechanism for Mdm2 to promote tumor progression.
- This Mdm2-Slug interaction drives cancer progression independently of p53 status, highlighting a potential therapeutic target in p53-null cancers.
Related Concept Videos
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Nonsense-mediated mRNA Decay
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
